Clin2
NCT07453589Likely a fitNot yet recruiting

Ultrasound and antibody tests for celiac disease activity

Celiac DiseaseUltrasoundTissue Transglutaminase AntibodySmall Bowel Ultrasonography

Part of Digestive system, Hormones & metabolism clinical trials.

This study uses ultrasound imaging of the small bowel along with antibody blood tests to check for celiac disease activity. It may help monitor the disease or screen people who might have it.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
140 people
Ages
2 years and older
Study type
Observational

Who can take part

  • You are 2 years or older.
  • You have symptoms like chronic diarrhea, belly swelling, weight loss, or poor growth that might be celiac disease.
  • You are newly diagnosed with positive blood tests or a biopsy confirming celiac disease.
  • You have celiac disease and are on a gluten-free diet and need a follow-up check.
  • You have a close family member with celiac disease and want to be screened.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07556328Recruiting
Understanding Small-Bowel Disease Through Tissue Analysis

This research study examines tissue samples from your small bowel (the part of your digestive system after your stomach) to better understand celiac disease and related conditions. By studying these samples in detail, researchers hope to improve how doctors diagnose and treat small-bowel diseases.

Tampere
NCT07701655Not yet recruiting
Personalized approach to diagnosing celiac disease

This study aims to improve how doctors diagnose celiac disease by looking at your blood test and biopsy results together. It may help create a more personalized diagnosis for people being evaluated for celiac disease.

NCT07377565Recruiting· Phase 1
Testing a new diagnostic for celiac disease during endoscopy

This study tests a new medicine called HB-2121 used as a diagnostic tool during an upper endoscopy to help improve detection of celiac disease. It's designed for people who are already scheduled for this procedure and may help doctors see the gut damage caused by celiac more clearly.

Stanford, California
NCT05983978Recruiting
Can a Blood Test Replace Biopsy for Celiac Disease?

This study looks at whether a simple blood test (tTG-IgA) can diagnose celiac disease without needing a biopsy. It includes children and adults who eat gluten and have certain blood test results.

Terrassa, Barcelona
NCT03136731Enrolling by invitation
Screening strategies for celiac disease in families and patients

This study tests practical, evidence-based screening approaches for celiac disease—either for family members of people with celiac disease or for people who already have it diagnosed. It may help improve how celiac disease is checked earlier and more accurately.

Tampere
NCT06059716Recruiting
Gluten detection and education for new celiac diagnosis

This study helps people newly diagnosed with celiac disease learn to use a gluten-detection device and get education to better manage their diet and health.

Chicago, Illinois

Hear when a new Celiac Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.